Psychometric properties of the processes of change scale for smoking cessation in UK adolescents. by Guo, B, Fielding, A, Sutton, S, Aveyard, P

The factor structure and factorial invariance for the decisional balance scale for adolescent smoking. by Guo, B, Aveyard, P, Fielding, A, Sutton, S

Do the Transtheoretical Model processes of change, decisional balance and temptation predict stage movement? Evidence from smoking cessation in adolescents. by Guo, B, Aveyard, P, Fielding, A, Sutton, S

Testing the convergent and discriminant validity of the Decisional Balance Scale of the Transtheoretical Model using the Multi-Trait Multi-Method approach. by Guo, B, Aveyard, P, Fielding, A, Sutton, S

Using latent class and latent transition analysis to examine the transtheoretical model staging algorithm and sequential stage transition in adolescent smoking. by Guo, B, Aveyard, P, Fielding, A, Sutton, S

High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. by Patel, B, Richards, S, Rowe, J, Goldstone, A, Fielding, A

The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protoc... by Foroni, L, Mitchell, W, Rai, L, Richards, S, Fielding, A, Goldstone, A

The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study by Patel, B, Goldstone, A, Ross, P, Richards, S, Foroni, L, Chopra, R, Fielding, A

Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study by Patel, B, Goldstone, A, Ross, P, Foroni, L, Richards, S, Chopra, R, Fielding, A

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study. by Rai, L, Casanova, A, Moorman, A, Richards, S, Buck, G, Goldstone, A, Fielding, A, Foroni, L

Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKAL... by Foroni, L, Mitchell, W, Rai, L, Casanova, A, Patel, B, Richards, S, Fielding, A, Goldstone, A

Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. by Foroni, L, Mitchell, W, Rai, L, Casanova, A, Gerrard, G, Patel, B, Richards, S, Fielding, A, Goldstone, A

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) U... by Moorman, A, Harrison, C, Richards, S, Fielding, A, Tallman, MS, Litzow, MR, Rowe, J, Goldstone, A, Dewald, G

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. by Chilton, L, Buck, G, Harrison, C, Ketterling, R, Rowe, J, Tallman, MS, Goldstone, A, Fielding, A, Moorman, A

The effect of food on the single dose pharmacokinetics of cediranib by Jayson, G, Evans, T, Harris, A, Mitchell, C, Kelly, C, Middleton, M, Fielding, A, Laud, P, Robertson, J, Puchalski, T

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome by Chilton, L, Buck, G, Harrison, C, Ketterling, R, Rowe, J, Tallman, MS, Goldstone, A, Fielding, A, Moorman, A

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome by Chilton, L, Buck, G, Harrison, C, Ketterling, R, Rowe, J, Tallman, MS, Goldstone, A, Fielding, A, Moorman, A

Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study by Fielding, A, Richards, S, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Rowe, J, Tallman, MS, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A